In addition to lowering blood glucose, GLP-1RAs can increase feelings of fullness, promote weight loss, and have potential benefits in cardiovascular protection
Prolonged maternal separation disturbs the serotonergic system during early brain development
Both of these groups exhibited increased stiffness in comparison to the control, however, the difference was not statistically significant
Anderson, MD, MAS, an assistant professor of medicine from the University of Pittsburgh, clinical trials of several GLP-1 receptor agonists like semaglutide (Wegovy/Ozempic, Novo Nordisk) for weight loss included exclusion criteria of chronic medical and psychiatric conditions. However, [FDA] labeling does not restrict these treatments in these populations, they wrote in JAMA Internal Medicine
Neira G, Hernndez-Pardos AW, Becerril S, Ramrez B, Valent V, Moncada R, et al